Results 231 to 240 of about 1,094,941 (330)

Blue Light Defocus Induces A Positive Effect on Refractive Status and Ocular Health: A Randomized Crossover Trial. [PDF]

Glob Chall
Wu J, Xu ZH, Miao Y, Zheng X, Yang L, Wang C, Yam JC, Jin ZB.   +7 more
europepmc   +1 more source

Time-Varying Betas and Cross-Sectional Return-Risk Relation: Evidence from the UK

, 2000
P. M. Fraser, Foort Hamelink, Martin Hoesli, Bryan D. Macgregor   +3 more
openalex   +1 more source

Time-varying betas

, 2012
openaire   +1 more source

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund, Johan Reutfors, Thomas Frisell, Fredrik Piehl   +3 more
wiley   +1 more source

ASPEN: Robust detection of allelic dynamics in single cell RNA-seq. [PDF]

PLoS Comput Biol
Petrova V, Niu M, Vierbuchen TS, Wong ES.   +3 more
europepmc   +1 more source

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang   +9 more
wiley   +1 more source

Fast PET reconstruction with variance reduction and prior-aware preconditioning. [PDF]

Front Nucl Med
Ehrhardt MJ, Kereta Z, Schramm G.
europepmc   +1 more source

Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1H‐MRS Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Myotonic dystrophy type 2 (proximal myotonic myopathy, PROMM) is a progressive multisystem disorder with muscular symptoms (proximal weakness, pain, myotonia) and systemic manifestations such as diabetes mellitus, cataracts, and cardiac arrhythmias.
Alexander Gussew, Maryam Kargaran, Maik Rothe, Andreas Deistung, Dietrich Stoevesandt, Walter A. Wohlgemuth, David Strube, Thomas Kendzierski, Anna Katharina Kölsch, Maurits Gerhard Abraham Heuschen, Markus Otto, Alexander Mensch   +11 more
wiley   +1 more source

Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations. [PDF]

Diabetologia
Subramanian V, Sherman AS, Holst JJ, Knop FK, Vilsbøll T, Bagger JI.   +5 more
europepmc   +1 more source

Cross-sectional Analysis of Swedish Stock Returns with Time-varying Beta

, 2000
Hossein Asgharian
openalex   +1 more source